227 related articles for article (PubMed ID: 11350871)
1. Cyclooxygenease-2 and hepatocellular carcinoma: is it a target for prevention?
DuBois RN
Clin Cancer Res; 2001 May; 7(5):1110-1. PubMed ID: 11350871
[No Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
Koga H
Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
[TBL] [Abstract][Full Text] [Related]
3. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
4. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
5. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
6. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
7. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
8. [Safe use of anti-inflammatory analgesics].
Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
[No Abstract] [Full Text] [Related]
9. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
10. Mechanisms underlying chemoprevention of ovarian cancer.
Mills GB
Clin Cancer Res; 2002 Jan; 8(1):7-10. PubMed ID: 11801533
[No Abstract] [Full Text] [Related]
11. [COX-2 inhibitor to whom?].
Martio J
Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
[No Abstract] [Full Text] [Related]
12. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
13. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
14. Beneficial effect of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with asthma during viral infection.
Varner AE
J Infect Dis; 2002 Sep; 186(5):723; author reply 723-4. PubMed ID: 12195364
[No Abstract] [Full Text] [Related]
15. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
16. Cutting-edge pharmacotherapeutics.
Mege J
Pa Med; 1998 Dec; 101(12):17, 22. PubMed ID: 9883028
[No Abstract] [Full Text] [Related]
17. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
Costantino S
Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276
[No Abstract] [Full Text] [Related]
18. COX-2-selective inhibition: a new advance in pain management. Chairman's introduction.
Korttila K
Eur J Anaesthesiol Suppl; 2002; 25():1-2. PubMed ID: 12449671
[No Abstract] [Full Text] [Related]
19. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
20. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
Davis P; Juby A; Robertson S; Richard N
J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
